SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: same story, different vaccine M Etemadifar, N Sedaghat, H Nouri, N Lotfi, A Chitsaz, R Khorvash, ... Multiple Sclerosis and Related Disorders 57, 103417, 2022 | 21 | 2022 |